Personalized TB treatment study
Treatments studied
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have TB in your lungs that is likely to respond to standard TB medicines.
- You are 18 years or older (or have parent/guardian consent if younger).
- You are generally able to care for yourself (score of 50 or higher on a daily activity scale).
- You have had blood tests showing your liver, kidneys, and blood counts are within safe limits.
- If you are living with HIV, your CD4 count is at least 50 and you are on or starting HIV treatment.
- You are not pregnant or breastfeeding, and if you can become pregnant, you agree to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This study tests whether two medicines, metformin and N-acetylcysteine, can help your lungs heal better after tuberculosis (TB). You will receive one of these study drugs along with your regular TB treatment.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.